International Clinical Trial: Comparison of the efficacy of 10-day high-dose vonoprazan and 14-day standard-dose vonoprazan combined with amoxicillin for helicobacter pylori eradication: a multicentre, non-inferiority, randomised controlled study

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132909) titled 'Comparison of the efficacy of 10-day high-dose vonoprazan and 14-day standard-dose vonoprazan combined with amoxicillin for helicobacter pylori eradication: a multicentre, non-inferiority, randomised controlled study' on Sept. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Helicobacter pylori infection

Intervention: 14-day standard dose vonoprazan with amoxicillin group:Vonoprazan (Walker, Takeda Pharmaceutical Company Limited, Hikari Plant): 20mg twice a day. Amoxicillin (Amoxcin, Zhuhai Federal Pharmaceutical Co., Ltd.): 10...